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Abstract
Exposure to heavy metals and organic solvents are potential etiologic factors for multiple sclerosis 
(MS), but their interaction with MS-associated genes is under-studied. We explored the 
relationship between environmental exposure to lead, mercury, and solvents and 58 single 
nucleotide polymorphisms (SNPs) in MS-associated genes. Data from a population-based case-
control study of 217 prevalent MS cases and 496 age-, race-, gender-, and geographically-matched 
controls were used to fit conditional logistic regression models of the association between the 
chemical, gene, and MS, adjusting for education and ancestry. MS cases were more likely than 
controls to report lead (odds ratio (OR)=2.03; 95% confidence interval (CI): 1.07, 3.86) and 
mercury exposure (OR=2.06; 95% CI: 1.08, 3.91). Findings of potential gene-environment 
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interactions between SNPs in TNF-α, TNF-β, TCA-β, VDR, MBP, and APOE, and lead, mercury, 
or solvents should be considered cautiously due to limited sample size.
Keywords
autoimmune diseases; heavy metal exposure; epidemiology; case-control; gene-environment 
interaction; organic solvents multiple sclerosis
Introduction
Multiple sclerosis (MS) is a complex disease with an etiology that is hypothesized to involve 
both environmental and genetic factors.1 Environmental agents are believed to trigger a T-
cell-mediated chronic inflammatory response to myelin proteins in individuals with a 
genetic predisposition, creating the characteristic lesions that cause disease.2 Therefore, 
examining environmental stressors and genes that modulate the immune system 
concurrently represent the best starting point for exploring the etiology of MS. Numerous 
environmental exposures such as heavy metals, organic solvents, ultraviolet radiation, 
infection, and diet have been investigated as possible etiologic factors for MS with 
inconsistent findings.1,3–10
The cellular accumulation of lead and mercury has been associated with the development of 
autoantibodies against neuronal cytoskeletal proteins, neurofilaments, and myelin basic 
protein in humans and animals.11–13 Overexposure to lead and mercury ions is known to be 
neurotoxic, particularly to motor neurons.14 Low-to-moderate levels of lead exposure can 
cause functional alterations in T-lymphocytes and macrophages that lead to increased 
hypersensitivity and can alter cytokine production, which increases risk of inflammation-
associated tissue damage.15 In non-predisposed animals, pretreatment with inorganic 
mercury can exacerbate autoimmune disease even prior to inducing disease.16 In genetically 
susceptible animals, mercury exposure even at low doses accelerates autoimmune disease 
and leads to disruption in cytokine production.13 These studies support an etiologic role of 
metals in autoimmune disease and suggest the importance of interactions between gene and 
environment, or between environmental factors in understanding metal toxicity.
Likewise, exposure to organic solvents, such as toluene or xylene, has been postulated to 
affect MS risk1,8 through altered immune function or neurotoxicity.8,17,18 Solvents have 
been linked to neurobehavioral changes, short-term memory impairment and loss of 
psychomotor functions.18 There is limited research on the effects of organic solvents on the 
immune system however a recent meta-analysis concluded that such exposure is 
significantly associated with an increased risk of autoimmune diseases, including MS, 
primary systemic vasculitis, and systemic sclerosis.17 Therefore, organic solvents likely 
exert their toxic effects through molecular mechanisms involving the immune system.
Studies of multiplex families, half-siblings, and adoptees have provided evidence for a 
genetic contribution to MS susceptibility.19 The most convincing evidence for a genetic 
component comes from twin studies which have shown heritability estimates ranging 
between 25% and 76%.20 Collectively, those studies suggest that multiple genes act either 
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independently or interactively with environmental factors to contribute to overall risk for 
MS. Several genetic loci for MS have been identified, including human leukocyte antigen 
(HLA) DRB1*1501 allele, interleukin 2 receptor alpha chain (IL2RA), and interleukin-7 
receptor alpha chain (IL7RA).21 Other immunomodulatory genes, such as the vitamin D 
receptor (VDR)22 myelin basic protein (MBP),23 tumor necrosis factor alpha and beta (TNF-
α/β),24 the T-cell antigen receptor beta (TCA-β),25 and apolipoprotein E (APOE)19 have 
plausible contributions to MS risk, but findings conflict.
Although it is believed that MS is multifactorial in etiology, little research has examined the 
joint role of environmental exposure to heavy metals or organic solvents and susceptibility 
to genes associated with an immune response and the subsequent development of MS.26 The 
objectives of this study were: 1) to estimate the independent associations between MS and 
heavy metals (lead, mercury)/organic solvents; and 2) to explore potential gene-environment 
interactions between each heavy metal/solvent and nine previously identified MS 
susceptibility genes.
Methods
Study design and population
The study population consisted of 866 individuals (276 cases and 590 controls) who 
participated in a multisite population-based case-control study led by the Agency for Toxic 
Substances and Disease Registry (ATSDR) in 2005-2009. The details of the study 
population and design have been previously described.27 Briefly, the study was conducted in 
four geographic areas of the US: the 28 counties comprising metropolitan Atlanta, Georgia; 
Lorain County, Ohio; the cities of Independence and Sugar Creek, Missouri; and the 19-
county area surrounding Lubbock, Texas. Cases were those with a diagnosis of definite MS 
under both the Poser28 and McDonald29 criteria. Controls were individuals without MS 
selected by random-digit-dialing methods from the same geographic areas as the cases and 
matched by gender, race, age, and year of birth. Response rates ranged from 36% to 43%; 
further details can be found in our previous paper27. For this analysis, 153 participants were 
excluded for the following reasons: Forty-five non-white and 12 Hispanic participants were 
excluded to reduce heterogeneity in the genetic results that would result due to differing 
allele frequencies and disease risk among racial/ethnic groups. An additional three (3) 
participants were excluded because they reported having an ancestor from Africa, Asia or 
the Middle East (1 case; 2 controls). Eighty-four (84) participants that did not provide a 
blood sample for genotyping (due to refusals, scheduling conflicts, and unsuccessful blood 
draws) were also excluded. Finally, nine (9) participants were excluded because of missing 
exposure data. Therefore, the final study population for the present analysis included 713 
participants (217 cases, 496 controls). Due to challenges in recruiting controls, the case: 
control ratio varied in the number of cases (1 to 4) and controls (1 to 12) per stratum.
Human subjects
Written informed consent was obtained from all participants. The study was approved by the 
Institutional Review Boards of the Centers for Disease Control and Prevention (CDC), Duke 
Napier et al. Page 3
Arch Environ Occup Health. Author manuscript; available in PMC 2016 January 20.
Author M
anuscript
Author M
anuscript
Author M
anuscript
Author M
anuscript
University Medical Center, Michigan Public Health Institute, the Texas Department of State 
Health Services, and the Cleveland Clinic.
Data collection and exposure assessment
Interview and data collection has also been described previously.27 Briefly, trained 
interviewers used computer-assisted telephone interviewing to collect information through 
questionnaires regarding demographics; lead, mercury, and solvent exposure history; 
established and hypothesized MS risk factors; family and medical histories; immunizations; 
residential and occupational histories; smoking; hobbies; and recreational activities. 
Questions from previous studies conducted by ATSDR, CDC, and our state health 
department collaborators were used to build the questionnaire. The questionnaire and study 
materials were refined and pilot-tested through focus groups of individuals with MS 
ineligible for participation or identified in a previous study of a metals smelter in EL Paso, 
Texas.27 For each chemical exposure, participants reported their exposure to it in any form 
(e.g. inhalation, skin contact, ingestion, other) on a regular basis at any time (e.g. “Were you 
exposed to lead in any form (fumes, dust, particles)?), specified whether exposure occurred 
at work or outside of work (e.g. recreation), and reported the year(s) of exposure. Exposure 
was dichotomized as present or absent for lead, mercury and solvents because exposure was 
not quantified, nor was intensity or duration captured with self-report responses. Cases were 
considered exposed if exposure occurred at least one year before symptom onset and 
unexposed if they had no history of exposure at the time of symptom onset. Controls were 
considered exposed if exposure occurred at least one year before the date of interview and 
unexposed if they had no history of exposure before date of interview. Cases (n=2) who 
reported exposure after MS symptom onset and controls (n=0) who reported exposure after 
interview date were reclassified as unexposed.
Specimen collection and genotyping
Participants provided a blood sample (3 EDTA Starstedt tubes of whole blood) after 
completing the questionnaire. Samples were frozen at -80°C before shipment on dry ice to 
the Center for Human Genetics at Duke University Medical Center for DNA extraction and 
genotyping. DNA was extracted from lymphocytes using the PUREGENE system 
(QIAGEN, Germantown, MD). Genotyping was performed using the TaqMan single 
nucleotide polymorphisms (SNP) genotyping assay (Applied Biosystems, Foster City, 
California, USA).
Gene and SNP selection
Based on evidence at the time the study was designed, a total of 58 SNPs in nine candidate 
genes were selected for analysis because of their potential role in MS development and 
association with an immune response. Seven genes were associated with MS in a previous 
genome-wide association study (GWAS) or association study (HLA DRB1*1501,21,30 
IL2RA,21 IL7RA,21 TCA-β,25 TNF-α,30 TNF-β,30 and APOE.19 Two additional genes — 
VDR and MBP — were selected because there was biological plausibility of an association 
between each one and MS in the literature.23,30,31 For all nine genes, we selected SNPs 
associated with MS from the literature or used a tag SNP approach to select SNPs.32 
Napier et al. Page 4
Arch Environ Occup Health. Author manuscript; available in PMC 2016 January 20.
Author M
anuscript
Author M
anuscript
Author M
anuscript
Author M
anuscript
Haplotype tagging SNPs were identified using LDSelect v1.033 based on data from the CEU 
population (Utah residents with ancestry from northern and western Europe) in the HapMap 
project (www.hapmap.org). To minimize redundancy among SNPs in high linkage 
disequilibrium, a single SNP was selected to represent each haplotype block, as defined by 
r2 > 0.64. SNPs were prioritized based on the potential for biological effect (coding SNPs, 
5′/3′ untranslated and regulatory regions), physical position, and allele frequency.
Statistical analysis
Hardy-Weinberg equilibrium (HWE) was tested in controls for all SNPs using PLINK 
1.0734 with an alpha level of 0.005 to determine statistical significance. Conditional logistic 
regression models were fit to account for the matched design.34 We calculated the odds ratio 
(OR) with 95% confidence intervals (CI) for the association between lead and MS, mercury 
and MS, and organic solvents and MS.
Gene-environment interaction was examined multiplicatively and additively using 
conditional logistic regression. To assess interaction on a multiplicative scale, we coded 
genotypes to count the number of minor alleles at each locus. We fit a model containing 
SNP and toxin main effects as well as a SNP-by-toxin interaction term. We calculated the 
95% CI for the interaction term, and performed a Wald chi-square test using an alpha level 
of 0.05 to determine its statistical significance. To assess interaction on an additive scale, we 
constructed binary genotype variables using a dominant model. We estimated stratum-
specific ORs and the relative excess risk due to interaction (RERI) and a 95% CI for each 
combination of joint effects according to Hosmer and Lemeshow.35 If the combined effect 
of risk factors was larger (or smaller) than the sum of the stratum-specific effects, there was 
interaction on an additive scale. RERI estimates the strength of the interactive effect 
compared to the effect without exposure.35 RERI values ≠ 0 indicate additive interaction 
(alpha=0.05).
All analyses were adjusted for educational level (≤ high school graduate vs. post-high school 
education) and ancestry using questionnaire data regarding paternal and maternal ancestry. 
Participants were asked to list up to three countries where ancestors came from and 
responses were grouped into geographic areas (Western Europe, Eastern Europe, 
Mediterranean, Scandinavia, US/Canada, Don't know). The proportion of ancestry from 
each geographic region was entered as a covariate in the analysis. Statistical analyses were 
performed using SAS 9.2 (SAS Institute Inc., Cary, North Carolina).
Results
The characteristics of the 713 participants in the present study are provided in Table 1. Four 
times as many participants were female as male, two-thirds of participants came from 
Georgia and Ohio, and 78% of participants had some college education. Respondents most 
commonly reported exposure to lead (13%), followed by mercury (9%), and organic 
solvents (6%). Approximately 62% of all participants reported no exposure to heavy metals 
or organic solvents while 12% reported exposure to one chemical and 5% reported exposure 
to more than one chemical. No SNPs were excluded from further analyses because of 
deviation from HWE.
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Environmental exposures and MS
After adjustment for education and ancestry, MS cases were more likely to report exposure 
to lead (adjusted OR (AOR)=2.03; 95% CI: 1.07,3.86) or mercury (AOR=2.06; 95% CI: 
1.08, 3.91) than controls. MS cases were less likely to report organic solvent exposure than 
controls (AOR=0.65; 95% CI: 0.28, 1.51) but this association was not statistically 
significant. Lead and mercury odds ratio estimates were more precise (i.e., had narrower 
confidence intervals) than solvent estimates.
Gene-environment interactions
Statistically significant (p<0.05) environmental interactions were identified on the 
multiplicative scale with SNPs in five of the genes examined (TNF-α, TNF-β, VDR, MBP, 
and APOE) (Table 2). For lead, there were six statistically significant environmental 
interactions identified: rs1799964/C (TNF-α), rs769178/T (TNF-β), rs2189480/T (VDR), 
rs3782905/C (VDR), rs4890785/T (MBP), and rs7412/T (APOE). For mercury, there were 
four statistically significant environmental interactions: rs1540339/T (VDR), rs2189480/T 
(VDR), rs2239186/G (VDR), and rs8096433/A (MBP). Three statistically significant 
environmental interactions were also identified with reported exposure to solvents: 
rs2238136/T (VDR), rs8096433/A (MBP), and rs17660901/G (MBP). One SNP modified the 
association of more than one exposure: rs8096433/A (MBP, with mercury and solvents); the 
estimates were on the same side of the null. The effect estimates for lead, mercury, and 
solvents were generally imprecise.
Additive interaction was identified between lead exposure and the rs17243/G allele in the 
TCA-β gene (See Supplemental Material, Table S1. The combined effect of having the 
rs1243/G allele and lead exposure was larger than the sum of the stratum-specific effects 
(ORobserved=2.05; 95% CI: 0.90, 4.67 vs. ORexpected=0.44), however the RERI was not 
significantly different from 0 (RERI=1.61; 95% CI: -0.02, 3.24). No evidence of additive 
interaction was observed between SNPs and mercury or SNPs and solvents (See 
Supplemental Material, Table S2 and S3). Similar to multiplicative interaction effect 
estimates, RERI values were generally imprecise.
Comment
Although MS is the most common non-traumatic neurologic disease disabling young adults 
in the United States,36 its cause remains unknown. Evidence indicates that it is a complex 
autoimmune disease caused by both environmental factors and genetic susceptibility.1 
However, limited research has focused on potential gene-environment interactions 
especially with regard to exposure to heavy metals and organic solvents. In this study, we 
examined exposure to lead, mercury, and solvents, and 58 SNPs in genes associated with 
MS, and identified statistically significant multiplicative interactions with SNPs in five of 
the genes (TNF-α, TNF-β, VDR, MBP, and APOE) and additive interaction with a SNP in 
TCA-β. Interestingly, although HLA DRB1*1501 (rs3135388) is the strongest genetic 
susceptibility allele for MS and SNPs for IL2RA and IL7RA (rs2104286 and rs6897932, 
respectively) exert modest effects on risk (ORs=1.1-1.3),21 none of those SNPs appeared to 
modify the relationship between any of the exposures and MS. Because of their role in 
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immune regulation and demonstrated association with MS risk, we had considered them the 
most plausible candidates for an interaction effect.
Existing epidemiologic evidence for the association between metals/solvents and MS is 
inconsistent partly due to small sample sizes, varying definitions of MS, exposure 
measurement, and whether they account for effect measure modification.7,17 We found that 
participants with MS were more likely to report exposure to lead and mercury than controls, 
which is consistent with some prior studies,5,37 but contrary to others.38 For the organic 
solvent-MS association, we found no association between organic solvents and MS in 
contrast to two meta-analyses suggesting an increase in risk with exposure (relative risk=1.7; 
95% CI: 1.1, 2.4 and OR=1.53; 95%CI: 1.02, 2.29).8,17 Our study may have lacked the 
power to detect an association because the prevalence of self-reported exposure to organic 
solvents in the study population was 6%.
Our results indicating possible multiplicative interaction between metals/solvents and SNPs 
in the MBP, VDR, APOE, TNF-α, and TNF-β genes are novel. Interestingly, joint effects 
were identified between SNPs tagging VDR and MBP and lead, mercury, and solvents, 
although the individual SNPs varied. If confirmed, these results may suggest that MBP and 
VDR are important modifiers of the association between lead, mercury, solvents, and MS. 
The protein encoded by the MBP gene is a major constituent of the myelin sheath of 
oligodendrocytes and Schwann cells in the nervous system and an obvious candidate for 
exploration of MS etiology. In animal models, inorganic mercury exposure and other heavy 
metals has been shown to produce antibodies against MBP.11–13 Vitamin D deficiency has 
been consistently associated with increased MS risk3 and functional variations in genes in 
the vitamin D pathway, including VDR, are expected to also influence MS risk, but evidence 
so far is mixed.39 A recent review suggested that the inconsistent associations between VDR 
polymorphisms and MS might reflect differences in environmental exposures that may 
modify a VDR-MS association.3 Genetic variability among VDR polymorphisms may also 
influence the way that vitamin D produces an effect on MS.39 Our results suggest that 
exposure to metals/solvents may help to explain these findings.
We identified joint effects between SNPs tagging APOE, TNF-α, and TNF-β, and lead 
exposure. As a major lipid carrier protein in the central nervous system, APOE has a 
putative role in immunomodulation and myelin repair. APOE has been identified as a 
genetic risk factor for increased disease severity, but inconsistently associated with disease 
susceptibility. Recent GWAS and large meta-analytic studies concluded that there is no 
association between APOE SNPs rs429358 (ε4) and rs7412 (ε2) and MS susceptibility.40,41 
Pro-inflammatory cytokines TNF-α and TNF-β located within the MHC III region are 
implicated in MS susceptibility and disease progression.42,43 Both have been detected in MS 
lesions and are associated with the deterioration of myelin, apoptosis of oligodendrocytes, 
activation of astrocytes, lymphocyte infiltration, and triggering of T-cell responses in 
MS.42–44
We also identified interactions between a SNP tagging TCA-β (rs17243/G) and solvents on 
the additive scale. On the additive scale, the presence of both lead exposure and the 
rs17243/G allele resulted in an increase in odds (ORobserved=2.05 (95% CI: 0.90, 4.67)) 
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rather than the decrease expected under the additive model (ORexpected=0.62+0.82-1=0.44). 
Had the RERI estimate been significantly different from zero, we would have been more 
confident in further quantifying the magnitude of the combined effect of the rs17243/G 
allele and lead exposure as 161% greater than the odds among those without the rs17243/G 
allele or lead exposure. T-cells are believed to be the main driver of autoimmune responses 
and inflammation in MS, but the effect of T-cell receptor polymorphisms, such as TCA-β, on 
MS pathogenesis is unclear.25 Our results suggest further exploration is warranted.
The associations suggested by this study may also have relevance for other autoimmune 
diseases because some autoimmune diseases may share a common origin. It has been 
demonstrated that genetic susceptibilities, pathologic mechanisms, clinical manifestations, 
and environmental risk factors may be common to multiple autoimmune diseases, an idea 
referred to as the autoimmune tautology.45 For example, smoking is of interest as an 
environmental risk factor for MS,46 irritable bowel syndrome,47 and rheumatoid arthritis.48 
In another example, PTPN2 and CTLA4, genes highly expressed in T lymphocytes, have 
been associated with type 1 diabetes and celiac disease.49 Thus, heavy metal and solvent 
exposure, and the genetic polymorphisms identified in this study, may similarly influence 
other autoimmune diseases and improve our understanding of mechanisms common to them. 
For autoimmune disease phenotypes in which a particular environmental factor plays a 
causative role, it would be helpful to distinguish these phenotypes as environmentally-
associated rather than idiopathic. However, there is lack of consensus on how to define these 
two types of autoimmune disease, and on the amount of evidence necessary and sufficient to 
classify an environmental exposure as a risk factor for disease.50 A strong exposure history 
that captures lifetime history of exposure across a variety of industries would be an integral 
part of such criteria.
Among the limitations of the study are a potential for recall error and exposure 
misclassification because exposure to heavy metals and solvents were assessed using self-
report. MS cases may be more likely to remember past exposure to chemicals than controls 
as they search their past for potential causes for their disease. In an effort to reduce potential 
recall error, interviewers provided participants with a worksheet of questions to answer 
before the phone interview and read off a list of chemicals by name during the interview, 
rather than asking open-ended questions. Both strategies are believed to improve subjects' 
reporting accuracy.51 Interestingly, there is evidence of little-to-no difference in the validity 
or reliability of self-reported occupational exposure assessments between cases and controls, 
so recall error may not be a significant source of bias if the exposure information is high 
quality.51 Environmental and occupational chemical exposures are often successfully 
retrospectively ascertained using questionnaires and interviews, despite recognized concerns 
with misclassification and recall bias.52–54 However, self-report is a broad assessment 
method that requires the participant to be aware of the specific chemicals to which they have 
been exposed occupationally and recreationally. Thus, self-reported exposure is likely an 
underestimation of the true exposure experience of our study population. While it was not 
possible to compare self-reported exposure with another metric in this study, self-reported 
exposure may correspond better to long-term exposure than other metrics (e.g. biomarkers) 
because it captures exposure from past residences and recreational activities.
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A second limitation of this study is that there may have been other interactions we could not 
detect due to the small sample size and low prevalence of environmental exposures in our 
population. Epigenetic mechanisms, which include changes in DNA methylation and histone 
modification, may independently affect aspects of MS disease such as inflammation and 
demyelination, but also may mediate the effects of environmental risk factors on MS and its 
clinical course. Thus, environmental risk factors and epigenetic changes likely interact in 
complex ways to modulate MS. Despite our best efforts in this present analysis, it is possible 
that the lack of association we observed between some environmental factors and genetic 
variants may be because our study focused exclusively on association with disease and was 
not designed to capture intermediate epigenetic mechanisms at play. As much as 75% of MS 
heritability is estimated to be unexplained by known genetic variants.55,56 Gene-
environment interactions may well account for some of this missing heritability. These 
interactions may be mediated by epigenetic mechanisms; if this is the case, studying 
epigenetic changes directly may result in higher power to detect gene × environment 
interactions.
A third limitation of this study is that incident MS cases were unavailable. Although we 
used prevalent cases, we restricted analysis to participants who reported exposure before 
symptom onset to maintain exposure-disease temporality. Finally, we note that adjusting for 
multiple comparisons using the Bonferonni correction (by adjusting the p value cutoff to 
correspond to a size of 0.05/45) would render all our reported interactions non-significant. 
Although customary in genetic epidemiology, the application of multiple testing methods is 
still an area of debate with no clear resolution.57–62 For the above reasons, our results may 
be considered exploratory until additional studies are conducted.
The main strength of this study is that it examines both the role of environmental exposure 
to metals/solvents and genetic factors in the development of MS using a population-based 
sample. Additionally, cases were identified using uniform ascertainment, an important 
consideration in multi-site studies, and were included in the study only if they were 
classified as having definite MS under both the McDonald and Poser criteria.28,29 Finally, 
because MS has a variable latency period, we only counted cases as exposed if that exposure 
occurred at least one year before symptom onset, thereby ensuring the temporality is 
maintained.
Conclusion
The present study addresses the lack of research about (1) the association between lead, 
mercury, organic solvents and MS, and (2) the joint association that MS susceptibility genes 
and heavy metals/organic solvents have on MS prevalence. Results from this study are a 
critical starting point for exploring the validity of the immunological hypothesis of MS 
pathogenesis for metal/solvent exposure. However, additional studies with a larger sample 
size and objective exposure measurement are needed to confirm our findings. Assuming our 
results are replicated in prospective studies that are not subject to the possible biases of 
retrospective studies such as recall bias, understanding how immunomodulatory genes and 
heavy metals/organic solvents interact to affect risk of MS may be important for dissecting 
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disease mechanisms in the future and informing prevention and treatment strategies for this 
debilitating disease.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Table 1
Demographic characteristics and self-reported exposure information of MS cases and 
controls (n=713)
Case (n=217)
n (%)
Control (n=496)
n (%)
State of Residence a,b
 Georgia 68 (31) 149 (30)
 Missouri 18 (8) 51 (10)
 Ohio 75 (35) 161 (32)
 Texas 56 (26) 135 (27)
Sexb
 Male 43 (20) 106 (21)
 Female 174 (80) 390 (79)
Education Attainedc
 Less than High School Graduate 8 (4) 19 (4)
 High School Graduate 46 (21) 84 (17)
 Some Colleg e/Technical School 69 (32) 153 (31)
 Graduated College 94 (43) 240 (48)
Lead Exposure d
 Yes 36 (17) 54 (11)
 No 139 (64) 368 (74)
 Don't know 42 (19) 74 (15)
Mercury Exposure d
 Yes 25 (12) 36 (7)
 No 161 (74) 417 (84)
 Don't know 31 (14) 43 (9)
Organic Solvents Exposured
 Yes 10 (5) 30 (6)
 No 188 (86) 446 (90)
 Don't know 19 (9) 20 (4)
No. of Exposures
 0 119 (55) 323 (65)
 1 34 (16) 55 (11)
 >1 11 (5) 23 (5)
 Don't know 53 (24) 95 (19)
aState lived in between Jan 1998 and Dec 2000 based on self-report.
b
Matching factor. Age at interview and race/ethnicity were also matching factors (not shown).
c
Highest level of education completed based on self-report.
dSelf-reported exposure. Among MS cases, exposure was at least 1 year prior to MS symptom onset. Among controls, exposure was at least 1 year 
prior to interview.
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